Trial intelligence / Profile preview

Desirudin vs Heparin for DVT Prophylaxis in Cardiothoracic Surgery

NCT00329433Phase 3Completed

Sponsor
Washington University School of Medicine
Start
May 2006
Primary completion
Oct 2008
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of desirudin in deep vein thrombosis (DVT), sponsored by Washington University School of Medicine. Started May 2006; status: completed.

02

Drugs

desirudin
03

Conditions

deep vein thrombosis (DVT)

Beyond the preview

Go deeper on NCT00329433.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00329433.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call